{"altmetric_id":4686123,"selected_quotes":["$MRK FDA puts Keytruda brain tumor trial on hold due to AE","$MRK Keytruda seems to have hit a roadblock, experiencing adverse event in GBM","So far, this's not a good day for $BMY or $MRK","Drug discovery is tough esp when you consider all the work to get this far and then fail 9\/10 times.","$MRK was asked about the glioma hold. They said it's nothing."],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["National Cancer Institute (NCI)"],"first_seen_on":"2015-10-28T12:00:07+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1486042543,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02359565?term=dipg&rank=23","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02359565?lup_d=30&lup_s=01%2F11%2F2015&recr=Open&term=cancer","https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02359565?lup_d=14&lup_s=01%2F27%2F2015&no_unk=Y&recr=Open&sel_rss=mod14&show_rss=Y&term=cancer","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02359565"],"nct_id":"NCT02359565","pubdate":"2015-02-09T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas or Diffuse Intrinsic Pontine Gliomas","type":"clinical_trial_study_record"},"altmetric_score":{"score":28.4,"score_history":{"1y":26.9,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":28.4},"context_for_score":{"all":{"total_number_of_other_articles":8384697,"mean":7.0640567748593,"rank":318981,"this_scored_higher_than_pct":96,"this_scored_higher_than":8065549,"rank_type":"exact","sample_size":8384697,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":245710,"mean":9.7897159729598,"rank":15017,"this_scored_higher_than_pct":93,"this_scored_higher_than":230682,"rank_type":"exact","sample_size":245710,"percentile":93},"this_journal":{"total_number_of_other_articles":24640,"mean":10.543580096595,"rank":1060,"this_scored_higher_than_pct":95,"this_scored_higher_than":23580,"rank_type":"exact","sample_size":24640,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":1125,"mean":14.865697508897,"rank":76,"this_scored_higher_than_pct":93,"this_scored_higher_than":1049,"rank_type":"exact","sample_size":1125,"percentile":93}}},"demographics":{"poster_types":{"member_of_the_public":28,"researcher":6,"science_communicator":4},"users":{"twitter":{"cohorts":{"Members of the public":28,"Scientists":6,"Science communicators (journalists, bloggers, editors)":4}}},"geo":{"twitter":{"US":18,"CA":2,"AR":1,"GB":2,"CN":1}}},"counts":{"total":{"posts_count":43},"twitter":{"unique_users_count":38,"unique_users":["GoToPER","AndyBiotech","dhovekamp42","zbiotech","OpenOutcrier","23aloha","BioRunUp","MarcoBiotech","Here2TradeHey","Dayadog","Biotchinvestor","BioStocks","DonnaYoungDC","edwin_urrutia_","BursatilBiotech","mcpoz","MrPug94","Datamonitor_JA","realmaciej","ScripMandy","NedPagliarulo","texashalofund","PharmaceuticBen","Dereklowe","YuZhu4","octamer","Biotech2050","Datamonitor_DP","biotechyankee","Chempaths","pharmamaven","PPBIOConsWW","kenneth1crook","Datamonitor_AK","Datamonitor_JLW","Realorientation","dsx0221","bradloncar"],"posts_count":38},"facebook":{"unique_users_count":4,"unique_users":["755609614551584","728344267195541","762754710430337","283246995191790"],"posts_count":5}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/GoToPER\/status\/565181981713899520","license":"datasift","citation_ids":[4686123],"posted_on":"2015-02-10T16:14:19+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"565181981713899520"},{"url":"http:\/\/twitter.com\/AndyBiotech\/statuses\/824643349479063552","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T15:41:10+00:00","author":{"name":"Andy Biotech","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","description":"#Biotech Investor | Recovering Scientist | May have positions in mentioned names | Opinions are strictly my own and not intended as investment advice","id_on_source":"AndyBiotech","tweeter_id":"632341632","geo":{"lt":null,"ln":null},"followers":31846},"tweet_id":"824643349479063552"},{"url":"http:\/\/twitter.com\/dhovekamp42\/statuses\/824643406647480321","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:41:23+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1582},"tweet_id":"824643406647480321"},{"url":"http:\/\/twitter.com\/zbiotech\/statuses\/824643421268832258","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:41:27+00:00","author":{"name":"zach","image":"https:\/\/pbs.twimg.com\/profile_images\/2325159264\/qel321r9zxqce9paddxl_normal.png","description":"buy-side biotech analyst, equity options focus since late '90s...may have positions in names I discuss, opinions are my own","id_on_source":"zbiotech","tweeter_id":"19717430","geo":{"lt":null,"ln":null},"followers":14381},"tweet_id":"824643421268832258"},{"url":"http:\/\/twitter.com\/OpenOutcrier\/statuses\/824643427480567808","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:41:28+00:00","author":{"name":"Open Outcrier","url":"http:\/\/openoutcrier.com","image":"https:\/\/pbs.twimg.com\/profile_images\/839250027012849666\/hNeSdoWq_normal.jpg","description":"Real-time stock & option trading headlines, breaking news, rumors and strategy. Nothing we post constitutes investment advice; we may have positions in markets","id_on_source":"OpenOutcrier","tweeter_id":"2334614718","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":28693},"tweet_id":"824643427480567808"},{"url":"http:\/\/twitter.com\/23aloha\/statuses\/824643521823043584","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:41:51+00:00","author":{"name":"23aloha","image":"https:\/\/pbs.twimg.com\/profile_images\/875383720127209472\/S3MtM1Um_normal.jpg","description":"biotech trader, photographer, physical therapist, devoted mate, singer\/songwriter, and fan of nfl's burgundy and gold","id_on_source":"23aloha","tweeter_id":"210862918","geo":{"lt":45.00015,"ln":-62.99865,"country":"CA"},"followers":4952},"tweet_id":"824643521823043584"},{"url":"http:\/\/twitter.com\/BioRunUp\/statuses\/824643595806265344","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:42:09+00:00","author":{"name":"BioRunUp","url":"http:\/\/www.biorunup.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1551654777\/biorunup_official_logo_100x100_twitter_normal.png","description":"Biotech trader & founder of BioRunUp. We utilize long, short & options based strategies to maintain consistent gains in any market. Trade with our team!","id_on_source":"BioRunUp","tweeter_id":"102527566","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":31570},"tweet_id":"824643595806265344"},{"url":"http:\/\/twitter.com\/MarcoBiotech\/statuses\/824643634653908993","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:42:18+00:00","author":{"name":"Marco Biopharma Bot","url":"http:\/\/endpts.com","image":"https:\/\/pbs.twimg.com\/profile_images\/794344137235513344\/tuDDlcAV_normal.jpg","description":"I read the firehose of BioTwitter so biopharma execs don't have to. Fast trending links, mostly topical. A service from Endpoints News @endpts.","id_on_source":"MarcoBiotech","tweeter_id":"2810327237","geo":{"lt":null,"ln":null},"followers":796},"tweet_id":"824643634653908993"},{"url":"http:\/\/twitter.com\/Here2TradeHey\/statuses\/824643767554764800","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:42:49+00:00","author":{"name":"Tizz Taylor \ud83c\uddfa\ud83c\uddf8","image":"https:\/\/pbs.twimg.com\/profile_images\/878992304186552320\/BjGvwfIL_normal.jpg","id_on_source":"Here2TradeHey","tweeter_id":"1378304011","geo":{"lt":null,"ln":null},"followers":22},"tweet_id":"824643767554764800"},{"url":"http:\/\/twitter.com\/Dayadog\/statuses\/824643832310554628","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:43:05+00:00","author":{"name":"King of Cannabinoids","url":"http:\/\/www.the-ecs.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2914351309\/e34776686a80bd5faade4ddde7620fdc_normal.jpeg","description":"I tweet finance & the ENDOCANNABINOID system info. IAR\/CFP, Hemp\/Cannabis supporter, Chat with me for follow back, or you are a bot. NOT INVESTMENT ADVICE","id_on_source":"Dayadog","tweeter_id":"79567303","geo":{"lt":null,"ln":null},"followers":758},"tweet_id":"824643832310554628"},{"url":"http:\/\/twitter.com\/Biotchinvestor\/statuses\/824643947553132544","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:43:32+00:00","author":{"name":"Biotech Investor","image":"https:\/\/pbs.twimg.com\/profile_images\/827174423828459520\/JAk-47fV_normal.jpg","description":"Biotech Investor\/Scientist, skeptic and financial junkie.","id_on_source":"Biotchinvestor","tweeter_id":"2941994695","geo":{"lt":47.61038,"ln":-122.20068,"country":"US"},"followers":109},"tweet_id":"824643947553132544"},{"url":"http:\/\/twitter.com\/BioStocks\/statuses\/824643981934022656","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:43:41+00:00","author":{"name":"Bio Stocks\u2122","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000082257081\/6edd185661b40bfc2243f52e375155d6_normal.png","description":"The dream is free, but the hustle is sold separately.","id_on_source":"BioStocks","tweeter_id":"112872946","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":20847},"tweet_id":"824643981934022656"},{"url":"http:\/\/twitter.com\/DonnaYoungDC\/statuses\/824644394280222720","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:45:19+00:00","author":{"name":"Donna Young","url":"http:\/\/marketintelligence.spglobal.com\/our-thinking\/news.html","image":"https:\/\/pbs.twimg.com\/profile_images\/474939099648778240\/Ug76s07w_normal.jpeg","description":"All things Washington for pharma\/biotech, health care & science news - 'The pharma diviner' - Senior Reporter, S&P Global News","id_on_source":"DonnaYoungDC","tweeter_id":"593813785","geo":{"lt":38.89511,"ln":-77.03637,"country":"US"},"followers":6042},"tweet_id":"824644394280222720"},{"url":"http:\/\/twitter.com\/edwin_urrutia_\/statuses\/824644566489894914","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:46:00+00:00","author":{"name":"Edwin Urrutia","image":"https:\/\/pbs.twimg.com\/profile_images\/760328708909662208\/bY2YXIeS_normal.jpg","id_on_source":"edwin_urrutia_","tweeter_id":"3658932323","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":18188},"tweet_id":"824644566489894914"},{"url":"http:\/\/twitter.com\/BursatilBiotech\/statuses\/824645345107963905","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T15:49:06+00:00","author":{"name":"Bursatil Biotech","image":"https:\/\/pbs.twimg.com\/profile_images\/892931744445247488\/ErkV-4Hk_normal.jpg","description":"Especialista Sector de Biotecnolog\u00eda cotizando en Nasdaq \/\/ @rftraders  \/\/ @FinguruOk \/\/ Extra\u00f1ando C\u00f3digo Financiero @columnacodigo \/\/","id_on_source":"BursatilBiotech","tweeter_id":"2926129144","geo":{"lt":-34.61315,"ln":-58.37723,"country":"AR"},"followers":4351},"tweet_id":"824645345107963905"},{"url":"http:\/\/twitter.com\/mcpoz\/statuses\/824646861411774464","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T15:55:07+00:00","author":{"name":"Marc Possley","image":"https:\/\/pbs.twimg.com\/profile_images\/430833236776714240\/hqgGcHOf_normal.jpeg","description":"Retired, Husband, Dad, Granddad, Friend, Author, Quality & Cost Consultant, Respect opp views but block those who make personal attacks.","id_on_source":"mcpoz","tweeter_id":"20056379","geo":{"lt":null,"ln":null},"followers":110},"tweet_id":"824646861411774464"},{"url":"http:\/\/twitter.com\/MrPug94\/statuses\/824647221341614080","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:56:33+00:00","author":{"name":"Brian Shields","url":"http:\/\/www.latimes.com\/business\/la-fi-genentech-tarceva-settlement-20160607-snap-story.html","image":"https:\/\/pbs.twimg.com\/profile_images\/753058072768098304\/6Fqger_P_normal.jpg","description":"Former Army Aviator, USMA grad, Cancer Advocate, Pharma Whistleblower","id_on_source":"MrPug94","tweeter_id":"164254921","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":6115},"tweet_id":"824647221341614080"},{"url":"http:\/\/twitter.com\/Datamonitor_JA\/statuses\/824647266543792132","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T15:56:44+00:00","author":{"name":"Jack Allen","image":"https:\/\/pbs.twimg.com\/profile_images\/894566706651078657\/pw0zVPjN_normal.jpg","description":"Analyst covering the pharmaceutical and healthcare industry. Views expressed are my own and not recommendations.","id_on_source":"Datamonitor_JA","tweeter_id":"3367655830","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":579},"tweet_id":"824647266543792132"},{"url":"http:\/\/twitter.com\/realmaciej\/statuses\/824647796552765444","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T15:58:50+00:00","author":{"name":"Maciej R","image":"https:\/\/pbs.twimg.com\/profile_images\/657860020047073280\/rsgGDMok_normal.jpg","description":"Tech Startup Employee #4. Aerospace \/ Biotech \/ Pharma Investor. Masters Finance Baruch College. Westside Highway Cyclist. Community Board Member.","id_on_source":"realmaciej","tweeter_id":"3474290248","geo":{"lt":40.71427,"ln":-74.00597,"country":"US"},"followers":389},"tweet_id":"824647796552765444"},{"url":"http:\/\/twitter.com\/ScripMandy\/statuses\/824648872089694209","license":"gnip","rt":["Datamonitor_JA"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:03:06+00:00","author":{"name":"Mandy Jackson","url":"http:\/\/www.scripintelligence.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474210924400635904\/wXzB8YN1_normal.jpeg","description":"I am Managing Editor, US Commercial News, for the Informa Pharma Insights publications Scrip and The Pink Sheet. Views expressed here are strictly my own.","id_on_source":"ScripMandy","tweeter_id":"588507814","geo":{"lt":32.71533,"ln":-117.15726,"country":"US"},"followers":3243},"tweet_id":"824648872089694209"},{"url":"http:\/\/twitter.com\/NedPagliarulo\/statuses\/824649894531063808","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:07:10+00:00","author":{"name":"Ned Pagliarulo","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000847409118\/ba0be0c75c20d1002be4796c20812e54_normal.jpeg","description":"Editor @ BioPharma Dive | Covering biotech, pharma news  | @Georgetown alum","id_on_source":"NedPagliarulo","tweeter_id":"993581474","geo":{"lt":38.91706,"ln":-77.00025,"country":"US"},"followers":374},"tweet_id":"824649894531063808"},{"url":"http:\/\/twitter.com\/texashalofund\/statuses\/824650033739993091","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:07:43+00:00","author":{"name":"Texas HALO Fund","url":"http:\/\/texashalofund.com","image":"https:\/\/pbs.twimg.com\/profile_images\/438675331054968832\/3QUdKfG-_normal.jpeg","description":"A Texas Angel sidecar fund powered by the Houston Angel Network","id_on_source":"texashalofund","tweeter_id":"1131801044","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":463},"tweet_id":"824650033739993091"},{"url":"http:\/\/twitter.com\/PharmaceuticBen\/statuses\/824650236677263360","license":"gnip","rt":["Datamonitor_JA"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:08:32+00:00","author":{"name":"BenAdamsFierce","url":"http:\/\/www.fiercebiotech.com","image":"https:\/\/pbs.twimg.com\/profile_images\/897106803762376704\/AytUKfJ8_normal.jpg","description":"Editor of @FierceBiotech. So enden die Rosen, Blatt um Blatt.","id_on_source":"PharmaceuticBen","tweeter_id":"104112634","geo":{"lt":50.83673,"ln":-0.78003,"country":"GB"},"followers":2544},"tweet_id":"824650236677263360"},{"url":"http:\/\/twitter.com\/Dereklowe\/statuses\/824650420761026564","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:09:16+00:00","author":{"name":"Derek Lowe","url":"http:\/\/blogs.sciencemag.org\/pipeline","image":"https:\/\/pbs.twimg.com\/profile_images\/847712548610691072\/cWYWFBqx_normal.jpg","description":"Drug discovery chemist and blogger\n\nNote: all opinions, choices of topic, etc. are strictly my own \u2013 I don\u2019t in any way speak for my employer (or anyone else).","id_on_source":"Dereklowe","tweeter_id":"17393219","geo":{"lt":42.36565,"ln":-71.10832,"country":"US"},"followers":12704},"tweet_id":"824650420761026564"},{"url":"http:\/\/twitter.com\/YuZhu4\/statuses\/824651437703516160","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:13:18+00:00","author":{"name":"Yu Zhu","image":"https:\/\/pbs.twimg.com\/profile_images\/476456919171743744\/wKIInmBU_normal.jpeg","id_on_source":"YuZhu4","tweeter_id":"733717446","geo":{"lt":null,"ln":null},"followers":191},"tweet_id":"824651437703516160"},{"url":"http:\/\/twitter.com\/octamer\/statuses\/824653892097024001","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T16:23:03+00:00","author":{"name":"Krishna M","url":"http:\/\/pharmtastic.me\/","image":"https:\/\/pbs.twimg.com\/profile_images\/834846268128124928\/aisxs9ej_normal.jpg","description":"Scientist, Biotech investor, r\/GPCRs mod, @ChelseaFC fan, Hiker (22\/67 NE 4000 footers summited)","id_on_source":"octamer","tweeter_id":"100493791","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":143},"tweet_id":"824653892097024001"},{"url":"http:\/\/twitter.com\/Biotech2050\/statuses\/824655003356958723","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:27:28+00:00","author":{"name":"biotech 2050","image":"https:\/\/pbs.twimg.com\/profile_images\/863608078960398341\/8cI74Yxr_normal.jpg","description":"My tweets & RT are not to be used as investment advice. Do your own DD.  My top holds: $CELG $TGTX $HALO $ZIOP $ACAD $XLRN $OMED $XON $KPTI $SGMO $CRMD $ATNM","id_on_source":"Biotech2050","tweeter_id":"2494896473","geo":{"lt":null,"ln":null},"followers":2400},"tweet_id":"824655003356958723"},{"url":"http:\/\/twitter.com\/Datamonitor_DP\/statuses\/824655584440053761","license":"gnip","rt":["Datamonitor_JA"],"citation_ids":[4686123],"posted_on":"2017-01-26T16:29:47+00:00","author":{"name":"Dustin Phan","url":"http:\/\/datamonitorhealthcare.com","image":"https:\/\/pbs.twimg.com\/profile_images\/806004442210463744\/IIIu5zbJ_normal.jpg","description":"Oncology analyst at @Datamonitor_HC. Views expressed are my own.","id_on_source":"Datamonitor_DP","tweeter_id":"3367548777","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":183},"tweet_id":"824655584440053761"},{"url":"http:\/\/twitter.com\/biotechyankee\/statuses\/824676576503685121","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-26T17:53:12+00:00","author":{"name":"Biotech Junkie","image":"https:\/\/pbs.twimg.com\/profile_images\/584952041224581120\/8cnMQoBh_normal.jpg","description":"degenerate gambler","id_on_source":"biotechyankee","tweeter_id":"2934270659","geo":{"lt":null,"ln":null},"followers":520},"tweet_id":"824676576503685121"},{"url":"http:\/\/twitter.com\/Chempaths\/statuses\/824741878713217024","license":"gnip","citation_ids":[4686123],"posted_on":"2017-01-26T22:12:41+00:00","author":{"name":"Greg Wells","url":"http:\/\/bit.ly\/2v3wf4R","image":"https:\/\/pbs.twimg.com\/profile_images\/859832480853106688\/VyjZ-SBE_normal.jpg","description":"Medicinal & Organic Chemist. Ph.D. & still piling on! Following novel and creative chemistries, Drug R&D, healthcare and the environment.","id_on_source":"Chempaths","tweeter_id":"771005216326057984","geo":{"lt":39.96066,"ln":-75.60549,"country":"US"},"followers":85},"tweet_id":"824741878713217024"},{"url":"http:\/\/twitter.com\/pharmamaven\/statuses\/824807344672436224","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-27T02:32:49+00:00","author":{"name":"rc","image":"https:\/\/pbs.twimg.com\/profile_images\/673662737524719616\/l93i6QWL_normal.jpg","description":"Long term biotech investor, ex CEO\/CFO of large financial co's, Springsteen,Yankee & NY Giant fan. Love Italy, Hawaii, the beach and playing craps with friends.","id_on_source":"pharmamaven","tweeter_id":"243795494","geo":{"lt":null,"ln":null},"followers":1692},"tweet_id":"824807344672436224"},{"url":"http:\/\/twitter.com\/PPBIOConsWW\/statuses\/824849686389420033","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-27T05:21:04+00:00","author":{"name":"PPBI","image":"https:\/\/pbs.twimg.com\/profile_images\/801377942546874368\/7RVIJGCr_normal.jpg","description":"#ppbi #consulting #biotech #biotechnology #pharma #biopharma #fda #anda #clinicaltrials #fundraising #harvard #pennengineering","id_on_source":"PPBIOConsWW","tweeter_id":"603843536","geo":{"lt":null,"ln":null},"followers":723},"tweet_id":"824849686389420033"},{"url":"http:\/\/twitter.com\/kenneth1crook\/statuses\/824943758290669568","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-27T11:34:53+00:00","author":{"name":"Kenneth Crook","image":"https:\/\/pbs.twimg.com\/profile_images\/504760689823469568\/jRajRkmD_normal.jpeg","id_on_source":"kenneth1crook","tweeter_id":"2759565332","geo":{"lt":null,"ln":null},"followers":43},"tweet_id":"824943758290669568"},{"url":"http:\/\/twitter.com\/Datamonitor_AK\/statuses\/824953836456570881","license":"gnip","rt":["Datamonitor_JA"],"citation_ids":[4686123],"posted_on":"2017-01-27T12:14:56+00:00","author":{"name":"\u00c1ine Kyle","url":"http:\/\/www.datamonitorhealthcare.com","image":"https:\/\/pbs.twimg.com\/profile_images\/781076229717893120\/rJf8tmzy_normal.jpg","description":"Analyst at @Datamonitor_HC covering the pharmaceutical and healthcare industry. Views expressed are my own.","id_on_source":"Datamonitor_AK","tweeter_id":"1394254375","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":415},"tweet_id":"824953836456570881"},{"url":"http:\/\/twitter.com\/Datamonitor_JLW\/statuses\/824975612775452676","license":"gnip","rt":["Datamonitor_JA"],"citation_ids":[4686123],"posted_on":"2017-01-27T13:41:28+00:00","author":{"name":"Jared Louis Wolff","url":"http:\/\/www.linkedin.com\/in\/jaredlouiswolff","image":"https:\/\/pbs.twimg.com\/profile_images\/896026327060500481\/1a6r4Yj4_normal.jpg","description":"Brooklynite, Wisconsin badger, and healthcare market analyst - oncology focused. Views and opinions expressed are my own and are not recommendations.","id_on_source":"Datamonitor_JLW","tweeter_id":"788419260708184064","geo":{"lt":40.6501,"ln":-73.94958,"country":"US"},"followers":119},"tweet_id":"824975612775452676"},{"url":"http:\/\/twitter.com\/Realorientation\/statuses\/825022009633411072","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-27T16:45:49+00:00","author":{"name":"fangxiang","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"Realorientation","tweeter_id":"2873598200","geo":{"lt":null,"ln":null},"followers":16},"tweet_id":"825022009633411072"},{"url":"http:\/\/twitter.com\/dsx0221\/statuses\/825197965853679617","license":"gnip","rt":["AndyBiotech"],"citation_ids":[4686123],"posted_on":"2017-01-28T04:25:01+00:00","author":{"name":"Osis Du","image":"https:\/\/pbs.twimg.com\/profile_images\/820819911370911744\/F1d91b01_normal.jpg","description":"physical therapist, leader of sports medicine & rehabilitation center, clinical researcher in sports & rehab medicine, spine, myofascial energy techniques.","id_on_source":"dsx0221","tweeter_id":"454576793","geo":{"lt":29,"ln":120,"country":"CN"},"followers":239},"tweet_id":"825197965853679617"},{"url":"http:\/\/twitter.com\/bradloncar\/statuses\/827148492841820160","license":"gnip","citation_ids":[4686123],"posted_on":"2017-02-02T13:35:43+00:00","author":{"name":"Brad Loncar","url":"http:\/\/www.loncarblog.com","image":"https:\/\/pbs.twimg.com\/profile_images\/802810551923396608\/HzKaIQom_normal.jpg","description":"Entrepreneur, investor w\/ a #biotech focus, avid reader, KC native, alumnus of @univmiami. \ud83d\udc7b: bradloncar","id_on_source":"bradloncar","tweeter_id":"274233761","geo":{"lt":38.95362,"ln":-94.73357,"country":"US"},"followers":19106},"tweet_id":"827148492841820160"}],"facebook":[{"title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=778501115595767&id=755609614551584","license":"public","citation_ids":[4686123],"posted_on":"2015-07-01T21:06:10+00:00","summary":"Information of the PD1 immunotherapy drug Pembrolizumab:\n\nPembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas or Diffuse Intrinsic Pontine Gliomas\n\nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02359565?term=di","author":{"name":"How the Story of Childhood Cancer Ends","url":"https:\/\/www.facebook.com\/755609614551584","facebook_wall_name":"How the Story of Childhood Cancer Ends","image":"https:\/\/graph.facebook.com\/755609614551584\/picture","id_on_source":"755609614551584"}},{"title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1104855296211101&id=728344267195541","license":"public","citation_ids":[4686123],"posted_on":"2015-07-01T13:46:34+00:00","summary":"Greetings everyone.  It has taken a few days of praying and telling our immediate family before we wanted to let the rest of our friends and family in on our latest update in John's Journey.\n\nOur NYC trip last week was to enroll in a clinical trial at Sloa","author":{"name":"John's Journey","url":"https:\/\/www.facebook.com\/728344267195541","facebook_wall_name":"John's Journey","image":"https:\/\/graph.facebook.com\/728344267195541\/picture","id_on_source":"728344267195541"}},{"title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=912896442082829&id=762754710430337","license":"public","citation_ids":[4686123],"posted_on":"2015-07-04T11:53:45+00:00","summary":"This clinical trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (brain tumors) or diffuse intrinsic pontine gliomas (brain stem tumors) that have come back, progr","author":{"name":"DIPG awareness","url":"https:\/\/www.facebook.com\/762754710430337","facebook_wall_name":"DIPG awareness","image":"https:\/\/graph.facebook.com\/762754710430337\/picture","id_on_source":"762754710430337"}},{"title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=911998995505907&id=762754710430337","license":"public","citation_ids":[4686123],"posted_on":"2015-07-02T11:58:18+00:00","summary":"This clinical trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (brain tumors) or diffuse intrinsic pontine gliomas (brain stem tumors) that have come back, progr","author":{"name":"DIPG awareness","url":"https:\/\/www.facebook.com\/762754710430337","facebook_wall_name":"DIPG awareness","image":"https:\/\/graph.facebook.com\/762754710430337\/picture","id_on_source":"762754710430337"}},{"title":"Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=401620696687752&id=283246995191790","license":"public","citation_ids":[4686123],"posted_on":"2015-07-01T18:41:49+00:00","summary":"Please pray hard that this trial for DIPG paves the way to a cure! DIPG, so far is terminal upon diagnosis. Let's pray this changes!","author":{"name":"Go Gold Global","url":"https:\/\/www.facebook.com\/283246995191790","facebook_wall_name":"Go Gold Global","image":"https:\/\/graph.facebook.com\/283246995191790\/picture","id_on_source":"283246995191790"}}]}}